Semaglutide has become the industry standard for consistent appetite suppression and gradual weight loss
Do not hesitate to seek advice halitosis is a recognised clinical concern and healthcare professionals are well placed to help
116 YangGZhouR
Unlike the fat soluble vitamins A D E K, B vitamins are water soluble and not stored in the body
The judicial posture as of May 2026 has been broadly deferential to FDAs interpretation of its statutory authority
Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
